Articles by Angie Drakulich - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Angie Drakulich
« Previous
123456789101112
Next »

Global Healthcare on the Ground: Merck and AstraZeneca Tackle Cervical Cancer and Tuberculosis

Merck and AstraZeneca Tackle Cervical Cancer and Tuberculosis.
Nov 2, 2010
By: Angie Drakulich

Merck and AstraZeneca Tackle Cervical Cancer and Tuberculosis.

Innovation In Depth

Connecting science and policy might increase support for innovation.
Nov 2, 2010
By: Angie Drakulich

Connecting science and policy might increase support for innovation.

Biosimilars Hearing Begins Today

Nov 2, 2010
By: Angie Drakulich

Today begins the two-day public hearing being held at FDA headquarters in Rockville, MD, to gain public in put on how to implement and regulate the follow-on biologics pathway that was cleared via President Obama's Biologics Price Competition and Innovation Act of 2009, which falls under the 2010 approved healthcare reform legislation.

FDA Issues Draft Guidance for Qualifying Drug-Development Tools

Oct 28, 2010
By: Angie Drakulich

The US Food and Drug Administration issued a draft guidance last week on the Qualification Process for Drug Development Tools.

FDA Posts Minutes to PDUFA V Discussion Meeting

Oct 21, 2010
By: Angie Drakulich

The US Food and Drug Administration has posted on its website the minutes of the PDUFA V reauthorizaton stakeholder meeting.

FDA Reports on Advancing Regulatory Science

Oct 14, 2010
By: Angie Drakulich

The US Food and Drug Administration has released an implementation report on its Regulatory Science Initiative. The report outlines the agency's plans to advance regulatory science through new tools, standards, and approaches for assessing the safety, efficacy, quality and performance of FDA-regulated products, according to an agency press release.

USP Issues Explanatory Statement Regarding Recall of USP 33–NF 28

Oct 7, 2010
By: Angie Drakulich

The US Pharmacopeia released a statement this week that explains in more detail last January's recall of the United States Pharmacopeia 33–National Formulary 28 (USP 33–NF 28).

Global Healthcare on the Ground: The PATH Malaria Vaccine Initiative

A look at MVI's malaria work in developing countries.
Oct 2, 2010
By: Angie Drakulich

A look at MVI's malaria work in developing countries.

Amgen Recalls Products for Glass Flakes

Sep 30, 2010
By: Angie Drakulich

Amgen (Thousand Oaks, CA) issued a voluntary recall last week of certain lots of Epogen(R) and Procrit(R) (Epoetin alfa) vials.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
67%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
33%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here